TrialBMC medicine2026

Assessment of antibody responses to Anopheles SG6-P1 and Aedes N-term 34 kDa salivary peptides: a randomised human-challenge trial of controlled exposures to vector bites.

Victor Chaumeau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.